mefordis
If you can dream it, you can do it.
- Joined
- Jun 23, 2006
I’ll pass on the baby powder company.
After having to pay out 100 million in lawsuits I'll bet their safety practices are top notch.
I’ll pass on the baby powder company.
What do you mean?Another Monday morning, another vaccine announcement. Funny how that works.
The Oxford vaccine has come in this morning. It’s being wrongly reported as 70% efficacy- that’s across the entire trial- they’ve worked out on 50% initial dose and 100% second its 90% effective. Maybe because the delivery agent (a deactivated chimp virus) is actually attacked by the immune system if a 100% dose is given on first vaccination.
This is great news as the vaccine will go 25% further.
It’s a tenth of the cost of Moderna and can just be kept in normal fridges so could be the ultimate vaccine victor as it’s easy to transport and very cheap to make.
Doesn’t make sense.
Also, the half dose trial was only conducted on a couple thousand participants.
But, let’s assume that it is 70% effective for now. Anyone willing to get this over the other more effective vaccines?
Personally, I'm loving the weekly "Monday morning vaccine announcements". It's a great way to start the week. Maybe we'll get J&J next Monday.![]()
What do you mean?
Stock market.
But, let’s assume that it is 70% effective for now. Anyone willing to get this over the other more effective vaccines?
Well, I don't see the problem with wanting to benefit from creating a vaccine that will aid in getting the entire global population out of a pandemic. At least in the case of BioNTech...they've been working on the mRNA technology for 8 years, spending many millions of dollars on research. And thank goodness they'd done that work, because that's why we have this vaccine so quickly. And not for nothing, I'm betting that many of the people on these forums have 401Ks or retirement accounts that are likely broad based index type funds....and so not only are those people (me included), fortunate enough to get a vaccine soon, but we'll benefit to a certain degree from the success of these companies.
I agree with you, I wasn't the one who made the snarky comment.
https://www.iata.org/en/publications/travel-pass/
I believe that idea is what drove Biontech years ago to start developing their technology.. Correct me If I am wrong, but they were actually working on a flu vaccine and then Covid came along and they switched gears.I'm praying that these new technologies will also improve long-standing vaccinations. The fact that Flu vaccine sits at only 65% effective means that it totally needs to be a candidate for the new format, it would save millions of lives. There is such a lag in getting the Flu vaccine out that the main strain often shifts to one not in the selection. No reason to keep doing things the old way if there turns out to be a better way.
Yes its the only trial where they had participants self swabbing for the virus on a weekly basis, and they were not producing virus in the nose and airways.Apparently, the AstraZeneca vaccine has some proof that it reduces TRANSMISSABILITY of the virus. That is very good news. The lead researcher is speaking about it right now on CNN. It is the first vaccine in development that has evidence that it prevents transmission.
Simple solution to the transmission problem: just get vaccinated.
Simple solution to the transmission problem: just get vaccinated.
Agree.
It really is that simple. It's the same with flu, if you don't want it, get vaccinated (although I think the flu vaccine is less effective?). Otherwise you risk getting it.
But the flu shot is an option now for literally anyone who wants one. That's not the case yet with this vaccine.